|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/19/22 Green Vision Biotechnology Corp. 10-K/A 12/31/21 77:4.8M Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size
1: 10-K/A Amendment to Annual Report HTML 957K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
11: R1 Cover HTML 86K
12: R2 Consolidated Balance Sheets HTML 131K
13: R3 Consolidated Balance Sheets (Parenthetical) HTML 29K
14: R4 Consolidated Statements of Operations HTML 114K
15: R5 Consolidated Statements of Stockholdersdeficit and HTML 42K
Comprehensive Income
16: R6 Consolidated Statements of Cash Flows HTML 96K
17: R7 Organization and Nature of Business HTML 58K
18: R8 Basis of Presentation and Summary of Significant HTML 101K
Accounting Policies
19: R9 Going Concern HTML 25K
20: R10 Other Receivables HTML 32K
21: R11 Property, Plant and Equipment, Net HTML 35K
22: R12 Intangible Assets HTML 36K
23: R13 Inventories HTML 32K
24: R14 Concentrations of Credit Risk and Major Customers HTML 48K
25: R15 Other Payables HTML 30K
26: R16 Loss Per Share HTML 34K
27: R17 Related Parties Transactions and Balance HTML 39K
28: R18 Income Taxes HTML 47K
29: R19 Segment Information HTML 26K
30: R20 Comprehensive Income HTML 31K
31: R21 Discontinued Operations HTML 40K
32: R22 Legal Proceedings HTML 32K
33: R23 Common Stock HTML 28K
34: R24 Subsequent Event HTML 25K
35: R25 Basis of Presentation and Summary of Significant HTML 147K
Accounting Policies (Policies)
36: R26 Basis of Presentation and Summary of Significant HTML 65K
Accounting Policies (Tables)
37: R27 Other Receivables (Tables) HTML 32K
38: R28 Property, Plant and Equipment, Net (Tables) HTML 34K
39: R29 Intangible Assets (Tables) HTML 37K
40: R30 Inventories (Tables) HTML 32K
41: R31 Concentrations of Credit Risk and Major Customers HTML 49K
(Tables)
42: R32 Other Payables (Tables) HTML 29K
43: R33 Loss Per Share (Tables) HTML 32K
44: R34 Related Parties Transactions and Balance (Tables) HTML 36K
45: R35 Income Taxes (Tables) HTML 44K
46: R36 Comprehensive Income (Tables) HTML 30K
47: R37 Discontinued Operations (Tables) HTML 42K
48: R38 Organization and Nature of Business (Detail HTML 60K
Narrative)
49: R39 Basis of Presentation and Summary of Significant HTML 36K
Accounting Policies (Details)
50: R40 Basis of Presentation and Summary of Significant HTML 34K
Accounting Policies (Details 1)
51: R41 Basis of Presentation and Summary of Significant HTML 27K
Accounting Policies (Details 2)
52: R42 Basis of Presentation and Summary of Significant HTML 31K
Accounting Policies (Details Narrative)
53: R43 Going Concern (Details Narrative) HTML 25K
54: R44 Other Receivables (Details) HTML 31K
55: R45 Property, Plant and Equipment, Net (Details) HTML 34K
56: R46 Property, Plant and Equipment, Net (Details HTML 23K
Narrative)
57: R47 Intangible Assets (Details) HTML 29K
58: R48 Intangible Assets (Details 1) HTML 36K
59: R49 Intangible Assets (Details Narrative) HTML 22K
60: R50 Inventories (Details) HTML 33K
61: R51 Inventories (Details Narrative) HTML 22K
62: R52 Concentrations of Credit Risk and Major Customers HTML 48K
(Details)
63: R53 Other Payables (Details) HTML 28K
64: R54 Loss Per Share (Details) HTML 48K
65: R55 Related Parties Transactions and Balance (Details) HTML 31K
66: R56 Related Parties Transactions and Balance (Details HTML 25K
1)
67: R57 Income Taxes (Details) HTML 41K
68: R58 Income Taxes (Detail Narrative) HTML 32K
69: R59 Comprehensive Income (Details) HTML 41K
70: R60 Discontinued Operations (Details) HTML 48K
71: R61 Legal Proceedings (Details Narrative) HTML 29K
72: R62 Common Stock (Details Narrative) HTML 30K
75: XML IDEA XML File -- Filing Summary XML 139K
73: XML XBRL Instance -- gvbt_10k_htm XML 1.10M
74: EXCEL IDEA Workbook of Financial Reports XLSX 124K
8: EX-101.CAL XBRL Calculations -- gvbt-20211231_cal XML 112K
10: EX-101.DEF XBRL Definitions -- gvbt-20211231_def XML 263K
7: EX-101.LAB XBRL Labels -- gvbt-20211231_lab XML 679K
9: EX-101.PRE XBRL Presentations -- gvbt-20211231_pre XML 560K
6: EX-101.SCH XBRL Schema -- gvbt-20211231 XSD 155K
76: JSON XBRL Instance as JSON Data -- MetaLinks 284± 392K
77: ZIP XBRL Zipped Folder -- 0001640334-22-002058-xbrl Zip 241K
EXHIBIT 31.1
CERTIFICATION
| I, Lam Ching Wan, William, certify that: | |
|
|
|
| 1. | I have reviewed this Amendment to the Annual Report on Form 10-K of Green Vision Biotechnology Corp. (the “registrant”); |
|
|
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
|
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
|
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
|
|
|
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: September 19, 2022 |
|
| |
|
|
|
| |
|
|
| Chief Executive Officer |
|
| This ‘10-K/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/19/22 | |||
| For Period end: | 12/31/21 | 10-K | ||
| List all Filings | ||||